RecruitingNot applicableNCT06113705

Imaging and Biological Markers for Prediction and Identification of Glioblastoma Pseudoprogression: a Prospective Study.

Studying Glioblastoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Istituto Clinico Humanitas
Principal Investigator
Letterio S Politi, MD
Humanitas Research Hospital IRCCS, Rozzano-Milan
Intervention
18F-GE-180 PET(diagnostic_test)
Enrollment
75 enrolled
Eligibility
18 years · All sexes
Timeline
2023 – 2026

Study locations (1)

Collaborators

Mediolanum Cardio Research

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06113705 on ClinicalTrials.gov

Other trials for Glioblastoma

Additional recruiting or active studies for the same condition.

See all trials for Glioblastoma →

← Back to all trials